Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The World Institute on Disability (WID) is a prominent global non-profit organization dedicated to the design and implementation of public policy and programs that promote the full social and economic integration of people with disabilities. Founded in 1983 by leaders of the Independent Living movement, WID operates as a research and advocacy center focused on eliminating systemic barriers to accessibility, employment, and health equity. The organization provides expert consultancy services to governments, international bodies, and corporations to ensure inclusive practices in areas such as emergency preparedness and digital technology. While not a drug developer, WID is a key stakeholder in the healthcare ecosystem, advocating for the inclusion of disability perspectives in clinical research and healthcare delivery systems. Its work is essential for ensuring that medical advancements and public health initiatives are accessible to the global disability community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on World Institute on Disability.